Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Jun;47(3):94.
doi: 10.18773/austprescr.2024.019.

Lipid-lowering therapy in patients with a 'normal' LDL-C

No authors listed
Comment

Lipid-lowering therapy in patients with a 'normal' LDL-C

No authors listed. Aust Prescr. 2024 Jun.
No abstract available

Keywords: LDL cholesterol; ezetimibe; hypercholesterolaemia; statins.

PubMed Disclaimer

Comment on

  • Managing hypercholesterolaemia.
    Nelson AJ, Nicholls SJ. Nelson AJ, et al. Aust Prescr. 2024 Feb;47(1):7-14. doi: 10.18773/austprescr.2024.006. Aust Prescr. 2024. PMID: 38444897 Free PMC article. Review.

References

    1. Nelson AJ, Nicholls SJ. Managing hypercholesterolaemia. Aust Prescr 2024;47:7-14. 10.18773/austprescr.2024.006 - DOI - PMC - PubMed
    1. Commonwealth of Australia. Australian Guideline for assessing and managing cardiovascular disease risk. Department of Health and Aged Care; 2023. https://www.cvdcheck.org.au/ [cited 2024 Apr 23] - PMC - PubMed
    1. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. ESC Scientific Document Group . 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41:111-88. 10.1093/eurheartj/ehz455 - DOI - PubMed
    1. Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, et al. Cholesterol Treatment Trialists’ (CTT) Collaborators . The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012;380:581-90. 10.1016/S0140-6736(12)60367-5 - DOI - PMC - PubMed

LinkOut - more resources